Related Experiment Video

Updated: Aug 14, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

Christian Johannes Gloeckner1, Norbert Kinkl, Annette Schumacher

  • 1GSF-National Research Center for Environment and Health, Institute of Human Genetics, Munich-Neuherberg, Germany.

Human Molecular Genetics
|December 3, 2005
PubMed

Insights

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are linked to Parkinson disease (PD). The I2020T LRRK2 mutation increases kinase activity, suggesting a gain-of-function mechanism in PD pathology.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with autosomal dominant late-onset Parkinson disease (PD).
  • LRRK2 protein possesses multiple domains, including a GTPase (Roc) domain and a predicted kinase domain, classifying it within the Roco family and Ras/GTPase superfamily.
  • Understanding LRRK2's function and the impact of mutations is crucial for elucidating PD pathogenesis.

Purpose of the Study:

  • To investigate the subcellular localization of the LRRK2 protein.
  • To determine the enzymatic activity of LRRK2, specifically its autokinase activity.
  • To compare the activity of wild-type LRRK2 with the disease-associated I2020T mutant.

Main Methods:

  • Cell fractionation techniques were employed to isolate cellular components.
  • Immunofluorescence microscopy was utilized to visualize LRRK2 localization within cells.
  • Purified LRRK2 protein was subjected to in vitro assays to assess autokinase activity.

Main Results:

  • LRRK2 was found to be localized in the cytoplasm and associated with cellular membrane structures.
  • Purified LRRK2 protein exhibited autokinase activity.
  • The disease-associated I2020T LRRK2 mutant demonstrated a significant increase (approximately 40%) in autophosphorylation compared to wild-type LRRK2 in vitro.

Conclusions:

  • The findings indicate that LRRK2 is a cytoplasmic protein associated with cellular membranes.
  • LRRK2 possesses intrinsic autokinase activity.
  • The I2020T mutation linked to Parkinson disease enhances LRRK2 kinase activity, suggesting a gain-of-function mechanism contributes to PD pathology.

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...